7/11/2021Shanghai I-Mab  Enters Two New Oncology Partnerships

7/11/2021Biocytogen/Eucure Biopharma's CTLA-4 and CD40 mAbs Approved for Phase ...

7/9/2021MOFCOM Plans to Beef Up Scrutinization of Foreign Investment

7/9/2021Takeda's NDA for Mobocertinib (TAK-788) Accepted in China as a Treatme...

7/9/2021Recent Executive Moves

7/9/2021Innovent's NDA for FGFR1/2/3 Inhibitor (Pemigatinib) Accepted in China...

7/9/2021Schott Inaugurates New Glass Tubing Plant in China

7/8/2021Parexel Expands A/P Capability with New China Depot Planned

7/8/2021CDE Solicits Comments on the Technical Guidelines for Clinical Pharmac...

7/8/2021CDE Solicits Comments on the Technical Guidelines for Pharmacokinetic ...

7/8/2021CDE Solicits Comments on the Guidelines for Clinical Research of Late ...

7/8/2021CDE Solicits Comments on the Technical Guidelines for Writing Safety R...

7/8/2021Sparx Therapeutics to Build Its First ADC Production Facility in Yangz...

7/8/2021BeiGene/Amgen Wins Chinese Approval of KYPROLIS (Crfilzomib) for r/r M...

7/8/2021China Passes Data Security Law to Take Effect in Less Than Two Months

7/8/2021Revision of China's Anti-Monopoly Law to Close "Loopholes" in Anti-car...

7/8/2021Ex-Genentech Staffers Plead Guilty To Trade Secrets Theft as DOJ Targe...

7/8/2021Is China's Drug Regulator Suddenly Raising the Bar on Cancer Med R&D? ...

7/7/2021Further Updates on Patent Linkage and Patent Term Extension in China

7/7/2021NMPA Re-elected as ICH Management Committee Member

7/7/2021Lippo Healthcare, AstraZeneca Pens Deal for Investment in China's Grea...

7/7/2021Neurolief Enters Licensing Deal with NeuroFront for Relivion in Greate...

7/7/2021dMed-Clinipace Completes US$50M Series C+ Financing

7/6/2021Alibaba Health-Backed LinkDoc Files for U.S. IPO

7/6/2021Antengene Granted Chinese IND Approval for Phase II Trial of Single-...

7/6/2021NMPA Announces Package Insert Revision of Metoclopramide Products

7/6/2021Innovent and Laekna Enter a Partnership to Co-Develop Combo of Sinti...

7/6/2021CStone Granted Chinese IND Approval for I/O Candidate CS2006/NM21-14...

7/6/2021Y-mAbs Submits Chinese BLA for DANYELZA® (naxitamab-gqgk)

7/5/2021GSK Launches HIV Drug Dovato (dolutegravir/lamivudine) in China

Page:179/774 Total number of articles:23207: [First][<<] [177] [178] [179] [180] [181] [>>] [End]